CT scans from a lung cancer patient treated at MSK, taken from two different views. These images show the patient’s chest before TIL therapy and again six weeks after treatment. The pretreatment ...

Stage 3 non-small cell lung cancer has spread to nearby tissues and lymph nodes but not to more distant tissues. Most people with this stage have lung cancer symptoms. Treatment can depend on several ...

Treatment landscape of EGFR-mutant non–small cell lung cancer has evolved in the most recent years. In the metastatic setting, with combination approaches tested in first-line, whereas in the ...

Lung resection after initial nonoperative treatment for non-small cell lung cancer (NSCLC) was safe and led to significantly improved survival in select patients previously treated with nonoperative ...

Lung cancer in never-smokers exhibits distinct biological characteristics, often leading to late-stage diagnoses due to lack of screening. Targeted therapies, guided by molecular testing, offer ...

Researchers have developed a new nanomedicine therapy that delivers anticancer drugs to lung cancer cells and enhances the immune system's ability to fight cancer. The team showed promising results ...

Lung (pulmonary) sarcoma is a rare type of lung cancer. Most lung cancers start in epithelial cells that line your airways, but pulmonary sarcoma develops in connective tissue or other nonepithelial ...

Small cell lung cancer (SCLC) is a fast-growing cancer that forms in the lung. It's one of two types of lung cancer. The other type is non-small cell lung cancer (NSCLC). SCLC is less common than ...

Squamous cell carcinoma treatment varies by stage, involving surgery, radiation, and systemic therapies based on cancer progression and patient health. Stage 1 focuses on tumor removal, Stage 2 ...